Protionamide
Indications: - Multi-drug resistant Mycobacterium tuberculosis Source: EML workbook import

Fresh additions to the Afya Chain catalogue, ready for discovery and procurement.
Indications: - Multi-drug resistant Mycobacterium tuberculosis Source: EML workbook import
Formulations: - Oral > Solid > dispersible tablet: 150 mg Oral > Solid > tablet: 400 mg; 500 mg Indications: - Tuberculosis Source: EML workbook import
Formulations: - Oral > Solid: 150 mg Indications: - Tuberculosis Source: EML workbook import
Formulations: - Oral > Solid > tablet: 150 mg; 300 mg Oral > Solid > dispersible tablet: 150 mg Indications: - Tuberculosis - Latent tuberculosis Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 1 g powder for injection (as sulfate) as vial Indications: - Multi-drug resistant Mycobacterium tuberculosis Source: EML workbook import
Indications: - Multi-drug resistant Mycobacterium tuberculosis Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 40 mg in vial Oral > Liquid: 1 mg per mL powder for oral liquid; 4 mg per mL powder for oral liquid Oral > Solid > dosage form: 10 mg; 20 mg; 40 mg Indications: - Gastrointestinal bleeding - Peptic ulcer, site unspecified - Gastro-oesophageal reflux disease Source: EML workbook import
Formulations: - Oral > Liquid: 75 mg per 5 mL (as hydrochloride) Oral > Solid: 150 mg (as hydrochloride) Parenteral > General injections > unspecified: 25 mg per mL in 2 mL ampoule (as hydrochloride) Indications: - Peptic ulcer, site unspecified - Gastro-oesophageal reflux disease Source: EML workbook import
Formulations: - - Indications: - Contact with health services for contraceptive management Source: EML workbook import
Formulations: - - Indications: - Contact with health services for contraceptive management Source: EML workbook import
Indications: - Coagulation defects, purpura or other haemorrhagic or related conditions - Obstetric haemorrhage - Haemophilia A - Von Willebrand disease Source: EML workbook import
Formulations: - Injection: frozen liquid in bag or lyophilized powder in vial containing: > 50 IU Factor VIII > 100 IU vWF > 140 mg clottable fibrinogen per unit Indications: - Coagulation defects, purpura or other haemorrhagic or related conditions - Obstetric haemorrhage - Haemophilia A - Von Willebrand disease Source: EML workbook import
Ready to amplify your rewards? Drop your email and we'll be in touch soon.